New and Ongoing NIH Funding

The Division has eight active NIH-funded research grants. Betsy Herold, M.D., is Principal Investigator on a Program Project titled "Multitargeted Microbicide Combinations to Block HIV." In addition, Dr. Herold is a Project Leader on two additional Program Project Grants titled "Development of Sodium Dimandelic Acid as a Topical Microbicide for HIV and HSV" (PI: Mary Klotman, Mount Sinai 9/26/01-7/31/05), and "Topical Microbicides for Prevention of STDs/HIV" (PI: L. Stanberry, University of Texas, Galveston).

Roberto Posada, M.D., is Principal Investigator of the NICHD sponsored Pediatric AIDS Clinical Trials Subunit (Parent Unit: Harlem Hospital, PI: E. Abrams), which conducts clinical research related to HIV infection in pregnant women, infants, children, and adolescents. In addition, Dr. Posada is also a co-investigator on a multicenter Program on Solid Organ Transplantation in HIV (PI: P. Stokes and M. Roland, UCSF).

Maria-Arantxa Horga, M.D., continues her research funded by a KO8 from the NIH titled "Interaction of Parainfluenza virus 3 with the host cell." In addition, Dr. Herold (co-investigator) participates in an NIH funded training grant titled "Physician Scientist Research Training Pathogenesis of Viral Diseases" (PI: Mary Klotman).

Andrew Campbell, M.D., has been awarded a Career Development Award as part of the NIAID–funded Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE).